Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study

OBJECTIVE: This study examined long-term outcomes of biological disease-modifying antirheumatic drugs (bDMARDs) and tofacitinib discontinuation in patients with rheumatoid arthritis (RA). METHODS: Ninety-seven RA patients who desired drug discontinuation after sustained remission or low disease acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Shunsuke, Okada, Akitomo, Koga, Tomohiro, Ueki, Yukitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223309/
https://www.ncbi.nlm.nih.gov/pubmed/35737642
http://dx.doi.org/10.1371/journal.pone.0270391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223309/
https://www.ncbi.nlm.nih.gov/pubmed/35737642
http://dx.doi.org/10.1371/journal.pone.0270391

Ejemplares similares